Videoconferencing is a low cost, high quality way for a group to view a LIVE meeting from any location worldwide.
The delivery of our high quality Videoconference signal allows you and your group to feel like you're at the meeting without the hassle of traveling to the FDA meeting. When you connect to our high quality broadcast you will see video and slides as they are presented along with crisp, clean audio directly from the meeting. Along with video, we supply a direct feed from the FDA's slide presentation to your room so you view the highest quality presentation possible. The videoconference is our highest quality broadcast and the best experience throughout 8-10 hours of viewing for a group.
Stream Quality: Excellent
Cost: $1800.00 US
- Oncologic Drugs Advisory Committee
Meeting Date: 2/9/21-2/9/21
The committee will discuss supplemental biologics license application (sBLA) 125514/s-089, for KEYTRUDA (pembrolizumab), submitted by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. The proposed indication (use) for this product is for the treatment of patients with high-risk, early-stage triple-negative breast cancer, in combination with chemotherapy as neoadjuvant treatment, then as a single agent as adjuvant treatment after surgery. The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform.
|Location:||Please note that due to the impact of this COVID-19 pandemic, all meeting participants will be joining this advisory committee meeting via an online teleconferencing platform.||Related News Links:||Not Available|